Physician profile
Matthew E Johnson
NPI 1578536488
$161,906.87
in general payments reported to CMS, 2019-2025
31 companies · $476 in 2025
The $476 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108K · 2020: $7,680 · 2021: $11K · 2022: $20K · 2023: $12K · 2024: $2,117 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,687 · Travel and Lodging: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,080.00 |
| Food and Beverage | $2,687.19 |
| Travel and Lodging | $1,313.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $155,362.36 | 2019-2023 | Xarelto |
| Abbott Laboratories | $2,395.67 | 2019-2025 | Dragonfly Opstar, Xience Skypoint, Mitraclip |
| Medtronic, INC. | $1,698.26 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $501.31 | 2019-2020 | |
| Abiomed | $429.32 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $275.42 | 2019-2024 | Evkeeza |
| Edwards Lifesciences Corporation | $218.49 | 2019-2024 | Sapien 3 Ultra Resilia, Pascal |
| Cardiovascular Systems INC. | $142.82 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $136.57 | 2024-2025 | Optimizer |
| Philips North America LLC | $102.68 | 2022-2025 | Mcot |
| Astrazeneca Pharmaceuticals Lp | $72.07 | 2019-2024 | Wainua, Brilinta |
| Surmodics, INC. | $65.60 | 2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Pfizer INC. | $59.94 | 2019-2020 | |
| Itamar Medical INC | $50.69 | 2023 | Watchpatone |
| Ekos Corporation | $46.87 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $45.54 | 2019 | |
| Merck Sharp & Dohme LLC | $43.36 | 2022-2023 | Verquvo |
| Biosense Webster, INC. | $38.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.01 | 2023-2024 | |
| Amgen INC. | $29.85 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.26 | 2019-2024 | Lifevest |
| Penumbra, INC. | $24.09 | 2023 | Indigo System |
| Novo Nordisk INC | $18.62 | 2024 | Wegovy |
| Shockwave Medical, INC | $18.35 | 2021 | |
| Lantheus Medical Imaging, INC. | $15.83 | 2024 | |
| Arbor Pharmaceuticals, INC. | $15.77 | 2022 | |
| Boston Scientific Corporation | $15.24 | 2025 | Spaceoar Vue System - 10ml |
| Stryker Corporation | $14.80 | 2025 | Clottriever Bold Catheter |
| E.R. Squibb & Sons, L.L.C. | $12.99 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.